Hikma Pharmaceuticals News and Activities

Presence

Hikma Pharmaceuticals develops, makes, and sells generic and specialty medicines. Its main products include injectables, oral medicines, and branded treatments for hospitals, pharmacies, and healthcare providers.

Hikma Pharmaceuticals products and services overview:

Injectable medicines
Generic medicines
Branded medicines
Oral treatments
Oncology medicines
Respiratory treatments

Revenue: ~$3 billion

Employees: 9,500

Headquarters: London, United Kingdom (UK)

Hikma Pharmaceuticals is one of the...

Hikma Pharmaceuticals is a company listed under the stock ticker HIK (GB).

Hikma Pharmaceuticals has a direct presence in 2 countries.

They are in:

Pharmaceuticals67%
Fund33%

Executives

View the org chart displaying its 35 main executives

Most searched biographies at Hikma Pharmaceuticals

Popular executive movements at Hikma Pharmaceuticals

Khalid Nabilsi, who was Chief Financial Officer and Director, is promoted to Deputy Chief Executive Officer, North America and Europe (posted on February 26 2026).
Areb Kurdi who was Vice President of Finance and Accounting, becomes Acting Chief Financial Officer (posted on February 26 2026).
Victoria Hull, who was Director, is promoted to Chairman of the Board (posted on February 26 2026).

Click here to view some more movements at Hikma Pharmaceuticals

Create your alert
to follow the executive moves at Hikma Pharmaceuticals.